IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Molbio Diagnostics IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Salcete and caters to Healthcare sector. IIFL Securities , Jefferies India , Kotak Mahindra Capital Company , Motilal Oswal Investment Advisors are the merchant bankers of Molbio Diagnostics IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 22nd August 2025.
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
1,030.41 cr.
Sector: Healthcare
IPO so far:
29
Merchant Banker:
IIFL Securities
IPO by BRLM so far:
101
City:
Salcete
IPO so far:
0
Revenue (annualised):
₹
1020.42
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 28.91x
Molbio Diagnostics IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
IIFL Securities Limited is the book-running lead manager of the Molbio Diagnostics IPO. Kfin Technologies Limited is the Registrar for Molbio Diagnostics IPO.
Molbio Diagnostics IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Molbio Diagnostics IPO, based in Salcete, operates in the Healthcare sector with a focus on An innovative point-of-care (POC) diagnostics company. The company is launching its MainBoard Upcoming IPO on the BSE,NSE exchange, using the Book Building Issue method. Molbio Diagnostics IPO size is ₹ [●] with fresh issue size of ₹ 0 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Molbio Diagnostics IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Molbio Diagnostics IPO allotment status on the registrars website, Kfin Technologies Limited . Molbio Diagnostics IPO refund dates are [●].
Molbio Diagnostics IPO is expected to be listed on [●].
The upper price band for the Molbio Diagnostics IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Molbio Diagnostics IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Molbio Diagnostics IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Molbio Diagnostics IPO is finalised.
The merchant banker for Molbio Diagnostics IPO is IIFL Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited , Motilal Oswal Investment Advisors Limited . IIFL Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited , Motilal Oswal Investment Advisors Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Molbio Diagnostics IPO RHP for further details.
The registrar for Molbio Diagnostics IPO is Kfin Technologies Limited . Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Molbio Diagnostics IPO through their official website or helpline.
Molbio Diagnostics IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Get
Ready Image
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 1,030.41 Cr.
Sector: Healthcare
IPO so far:
29
Merchant Banker:
IIFL Securities
IPO by BRLM so far:
101
City:
Salcete
IPO so far:
0
Revenue (annualised):
₹ 1,020.42 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 28.91x
Molbio Diagnostics IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Molbio Diagnostics Financial Review Page
Merchant Banker(s) of Molbio Diagnostics IPO: IIFL Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited , Motilal Oswal Investment Advisors Limited
Molbio Diagnostics IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Molbio Diagnostics IPO listed at a listing price of against the offer price of .
The current market price of Molbio Diagnostics is .
Why Us?
